UK markets closed

WuXi Biologics (Cayman) Inc. (2269.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
12.620-0.620 (-4.68%)
At close: 04:08PM HKT
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
4,151,897
4,420,286
3,388,478
1,688,886
Depreciation & amortisation
-
800,674
481,783
303,009
Stock-based compensation
-
1,234,383
531,923
276,370
Change in working capital
-
-974,472
-963,326
-367,063
Inventory
-
-498,122
-783,185
-704,522
Other working capital
1,095,206
-326,717
-3,091,856
-4,143,504
Other non-cash items
-
-72,742
-45,127
-48,134
Net cash provided by operating activities
6,833,841
5,541,673
3,431,258
1,881,276
Cash flows from investing activities
Investments in property, plant and equipment
-5,738,635
-5,868,390
-6,523,114
-6,024,780
Acquisitions, net
-1,040
-281,040
-2,535,130
-155,239
Purchases of investments
-16,373,002
-10,770,982
-59,300,120
-20,353,451
Sales/maturities of investments
17,421,630
10,485,040
58,243,899
19,250,078
Other investing activities
-610,697
236,532
313,947
-28,011
Net cash used for investing activities
-5,134,629
-5,908,252
-9,601,670
-7,216,283
Net change in cash
-780,155
-2,608,058
1,907,545
890,239
Cash at beginning of period
8,135,290
9,003,280
7,095,735
6,205,496
Cash at end of period
7,273,809
6,395,222
9,003,280
7,095,735
Free cash flow
Operating cash flow
6,833,841
5,541,673
3,431,258
1,881,276
Capital expenditure
-5,738,635
-5,868,390
-6,523,114
-6,024,780
Free cash flow
1,095,206
-326,717
-3,091,856
-4,143,504